Metastatic Lung Non-Squamous Non-Small Cell Carcinoma trials recruiting in District of Columbia

Fewer than 3 recruiting trials found.

All Metastatic Lung Non-Squamous Non-Small Cell Carcinoma trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
  NCT04181060 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.